Categories AlphaGraphs, Earnings, Health Care
Key highlights from Biogen’s (BIIB) Q4 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today.
Total revenue fell 7% year-over-year to $2.54 billion.
Net income attributable to Biogen Inc. was $550.4 million, or $3.79 per share, compared to $368.2 million, or $2.50 per share, last year. Adjusted EPS rose 19% to $4.05.
Both the top and bottom line numbers beat expectations.
For the full year of 2023, adjusted EPS is expected to range between $15.00-16.00.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Everything you need to know about Medline’s IPO
After a modest start to the year, IPO activity rebounded in the second half of the year as recession fears eased and investor confidence increased. Medical supply company Medline Inc.
Chewy (CHWY): Three factors that work in favor of this pet retailer
Shares of Chewy, Inc. (NYSE: CHWY) gained over 1% on Monday. The stock has dropped 10% in the past three months. The pet products seller delivered solid results for the
Earnings Preview: Will cost pressures impact Darden Restaurants’ Q2 results?
Darden Restaurants, Inc. (NYSE: DRI), a full-service restaurant operator, has faced margin pressure this year from higher input costs tied to tariffs on key commodities. Despite that, management remains optimistic,
